CDK4/6 inhibitors in advanced breast cancer, what is beyond?
Saved in:
| Title: | CDK4/6 inhibitors in advanced breast cancer, what is beyond? |
|---|---|
| Authors: | Mohammed AA; Medical Oncology Department, Faculty of Medicine, Zagazig University, Egypt.; King Salman Armed Forces Hospital, Tabuk City, KSA., Rashied H; El-mabra Hospital, Zagazig, Egypt., Elsayed FM; Clinical Oncology & Nuclear Medicine, Department Faculty of Medicine Suez Canal University, Egypt. |
| Source: | Oncology reviews [Oncol Rev] 2019 Jul 29; Vol. 13 (2), pp. 416. Date of Electronic Publication: 2019 Jul 29 (Print Publication: 2019). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 101519906 Publication Model: eCollection Cited Medium: Print ISSN: 1970-5565 (Print) Linking ISSN: 19705557 NLM ISO Abbreviation: Oncol Rev Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31452841 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CDK4/6 inhibitors in advanced breast cancer, what is beyond? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mohammed+AA%22">Mohammed AA</searchLink>; Medical Oncology Department, Faculty of Medicine, Zagazig University, Egypt.; King Salman Armed Forces Hospital, Tabuk City, KSA.<br /><searchLink fieldCode="AU" term="%22Rashied+H%22">Rashied H</searchLink>; El-mabra Hospital, Zagazig, Egypt.<br /><searchLink fieldCode="AU" term="%22Elsayed+FM%22">Elsayed FM</searchLink>; Clinical Oncology & Nuclear Medicine, Department Faculty of Medicine Suez Canal University, Egypt. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101519906%22">Oncology reviews</searchLink> [Oncol Rev] 2019 Jul 29; Vol. 13 (2), pp. 416. <i>Date of Electronic Publication: </i>2019 Jul 29 (<i>Print Publication: </i>2019). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2E+A%22">Frontiers Media S. A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101519906 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1970-5565 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219705557%22">19705557 </searchLink><i>NLM ISO Abbreviation: </i>Oncol Rev <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31452841 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.4081/oncol.2019.416 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 416 Titles: – TitleFull: CDK4/6 inhibitors in advanced breast cancer, what is beyond? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mohammed AA – PersonEntity: Name: NameFull: Rashied H – PersonEntity: Name: NameFull: Elsayed FM IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 07 Text: 2019 Jul 29 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 1970-5565 Numbering: – Type: volume Value: 13 – Type: issue Value: 2 Titles: – TitleFull: Oncology reviews Type: main |
| ResultId | 1 |
